Sustained cutaneous remission with adalimumab in reactive arthritis: A case series

Dermatol Ther. 2020 Nov;33(6):e13965. doi: 10.1111/dth.13965. Epub 2020 Jul 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / therapeutic use
  • Antirheumatic Agents* / adverse effects
  • Arthritis, Reactive* / drug therapy
  • Arthritis, Rheumatoid* / drug therapy
  • Humans
  • Remission Induction
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Adalimumab